Properties of a P70 proteolytic factor of murine leukemia viruses

Cell
|November 1, 1977
PubMed

Insights

Murine leukemia viruses possess a unique protease that cleaves the P70 gag precursor protein into smaller viral polypeptides. This specific protease activity is essential for viral maturation and is inhibited by certain protease inhibitors.

Area of Science:

  • Virology
  • Molecular Biology
  • Proteomics

Background:

  • Murine leukemia viruses (MLVs), like Rauscher leukemia virus (RLV), are retroviruses known to cause leukemia in mice.
  • Viral maturation involves the proteolytic processing of precursor polyproteins into functional viral proteins.

Purpose of the Study:

  • To characterize the proteolytic factor responsible for cleaving the P70 gag precursor polyprotein in MLVs.
  • To investigate the properties and specificity of this viral protease.

Main Methods:

  • Partial purification of the proteolytic factor using Sephadex G-75 chromatography.
  • Analysis of P70 cleavage products under optimized conditions (detergent, DTT, pH, temperature, time).
  • Inhibition studies using various protease inhibitors (TLCK, TAME, CBZ-lysine, PMSF) and comparison with trypsin/chymotrypsin cleavage.

Main Results:

  • A unique proteolytic factor, with a molecular weight of 10,000-12,000 daltons, was identified in MLVs.
  • This factor specifically cleaves the P70 gag precursor into p30, p15, p12, and p10 polypeptides.
  • Inhibition studies suggest the protease shares characteristics with serine proteases, but exhibits unique cleavage specificity compared to trypsin or chymotrypsin.

Conclusions:

  • MLVs contain a specific, low-abundance protease essential for P70 processing.
  • The protease's unique characteristics differentiate it from host or other viral proteases.
  • Understanding this protease could offer insights into MLV replication and pathogenesis.